These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis. Skurikhin EG; Khmelevskaya ES; Pershina OV; Andreeva TV; Ermolaeva LA; Krupin VA; Ermakova NN; Reztsova AM; Stepanova IE; Dygai AM Bull Exp Biol Med; 2012 Sep; 153(5):638-43. PubMed ID: 23113245 [TBL] [Abstract][Full Text] [Related]
10. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis. Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416 [TBL] [Abstract][Full Text] [Related]
11. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734 [TBL] [Abstract][Full Text] [Related]
12. Antifibrotic activity of conjugates based on amphiphilic pluronic F68 and hydrophobic pluronic L31 with hyaluronate-endo-β-N-acetylhexosaminidase in pulmonary fibrosis. Skurikhin EG; Reztsova AM; Ermakova NN; Krupin VA; Pershina OV; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Reykhard DV; Goldberg VE; Dygai AM Bull Exp Biol Med; 2014 May; 157(1):5-9. PubMed ID: 24906958 [TBL] [Abstract][Full Text] [Related]
13. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis. Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884 [TBL] [Abstract][Full Text] [Related]
14. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice. Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239 [TBL] [Abstract][Full Text] [Related]
15. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215 [TBL] [Abstract][Full Text] [Related]
16. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [TBL] [Abstract][Full Text] [Related]
17. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Takemasa A; Ishii Y; Fukuda T Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751 [TBL] [Abstract][Full Text] [Related]
18. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567 [TBL] [Abstract][Full Text] [Related]
19. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice. Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib. Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]